Analysis of the mechanism of the magnesium effect on the warfarin-albumin interactionVAN DER GIESEN, W. F; WILTING, J.Biochemical pharmacology. 1984, Vol 33, Num 10, pp 1679-1681, issn 0006-2952Article

Interaction of warfarin with human serum albumin: a stoichiometric descriptionLARSEN, F. G; LARSEN, C. G; JAKOBSEN, P et al.Molecular pharmacology. 1985, Vol 27, Num 2, pp 263-270, issn 0026-895XArticle

Utilité de la surveillance biologique de l'héparinothérapie à visée curative = Usefulness of a biological supervision during curative heparinotherapyDEMICHELIS, C; COHEN, S; BRAGUER, D et al.Journal de pharmacie clinique (Paris). 1984, Vol 3, Num 3-4, pp 367-373, issn 0291-1981Article

The new understanding of the drug heparinJAQUES, L. B.Chest. 1985, Vol 88, Num 5, pp 751-754, issn 0012-3692Article

Contra: Antidotes for novel anticoagulants? ― Do we really need themEERENBERG, Elise S; LEVI, Marcel; BULLER, Harry R et al.Thrombosis and haemostasis. 2012, Vol 108, Num 4, pp 623-624, issn 0340-6245, 2 p.Article

Frequency of attendance at anticoagulant clinics: a prospective studyHOWARD, M. R; MILLIGAN, D. W.British medical journal (1857). 1988, Vol 296, Num 6626, issn 0007-1447Article

Effect of heparin in vivo on the in vitro assay of free thyroxineLINDSTEDT, G; LUNDBERG, P.-A; JAGENBURG, R et al.Scandinavian journal of clinical & laboratory investigation. 1983, Vol 43, Num 7, pp 643-646, issn 0036-5513Article

Hémostase Nouveaux anticoagulants: bien les connaître pour bien les prescrire : NOUVEAUTES EN MEDECINE 2011 (DEUXIEME PARTIE) = New anticoagulants: to know them in order to prescribe them appropriatelyBOEHLEN, F; DE MOERLOOSE, P.Revue médicale suisse. 2012, Vol 8, Num 324, pp 96-99, issn 1660-9379, 4 p.Article

Sulfated N-(carboxymethyl)chitosans: novel blood anticoagulantsMUZZARELLI, R. A. A; TANFANI, F; EMANUELLI, M et al.Carbohydrate research. 1984, Vol 126, Num 2, pp 225-231, issn 0008-6215Article

Intracranial fluid blood levels in the anticoagulated patientsLIVONI, J. P; MCGAHAN, J. P.Neuroradiology (Berlin. Print). 1983, Vol 25, Num 5, pp 335-337, issn 0028-3940Article

A collaborative study designed to establish the 4th international standard for heparinTHOMAS, D. P; CURTIS, A. D; BARROWCLIFFE, T. W et al.Thrombosis and haemostasis. 1984, Vol 52, Num 2, pp 148-153, issn 0340-6245Article

Les héparines = HeparinsLa Revue du praticien (Paris). 1988, Vol 38, Num 15, pp 917-964, issn 0035-2640, 44 p.Article

Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brainISHII, H; SALEM, H. H; BELL, C. E et al.Blood. 1986, Vol 67, Num 2, pp 362-365, issn 0006-4971Article

Monitoring the new antithrombotic drugsWALENGA, Jeanine M; HOPPENSTEADT, Debra A.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 6, pp 683-695, issn 0094-6176, 13 p.Conference Paper

La gestion actuelle des traitements anticoagulants et antibiotiques (1^re partie) Les anticoagulants: quels changements en 20 ans ?COGREL, Olivier.Les Nouvelles dermatologiques. 2011, Vol 30, Num SEP, pp 41-42, issn 0752-5370, 2 p., CAH2Conference Paper

The status of new anticoagulantsBATES, Shannon M; WEITZ, Jeffrey I.British journal of haematology. 2006, Vol 134, Num 1, pp 3-19, issn 0007-1048, 17 p.Article

PHENINDINE SOLUBILITY IN MIXED ORGANIC SOLVENTS: ANALYSIS OF THE ROLE OF SPECIFIC HYDROGEN AND NON-HYDROGEN BONDING INTERACTIONSPIPKIN JD; STELLA VJ.1983; INTERNATIONAL JOURNAL OF PHARMACEUTICS; ISSN 0378-5173; NLD; DA. 1983; VOL. 14; NO 2-3; PP. 263-277; BIBL. 1 P.Article

Comment donne-t-on une AMM pour un anticoagulant ? = How to obtain a marketing authorization for an anticoagulant drug?PAVLOVIC, Mira; MARC SAMAMA, Charles.STV. Sang thrombose vaisseaux. 2009, Vol 21, Num 4, pp 187-194, issn 0999-7385, 8 p.Article

Nouveaux anticoagulants : MALADIE THROMBOEMBOLIQUE VEINEUSE = New anticoagulants : VENOUS THROMBOEMBOLISMGODIER, Anne; MARTIN, Anne-Céline; LAKHDARI, Mourad et al.La Revue du praticien (Paris). 2011, Vol 61, Num 9, pp 1239-1243, issn 0035-2640, 5 p.Article

Etude et amélioration de l'usage des anticoagulants oraux dans un service hospitalier : évaluation des pratiques du service de cardiologie du centre hospitalier de SeclinROCHE, François-Xavier.2011, 72 p.Thesis

Heparin has its risks = L'héparine n'est pas sans risqueBROUHTON, Sandra.L'INFIRMIERE CANADIENNE. 1995, Vol 91, Num 8, pp 25-28, issn 1492-5494Article

Heparin and atherosclerosisENGELBERG, H.Advances in lipid research. 1983, Vol 20, pp 219-255, issn 0065-2849Article

Safe anticoagulation with danaparoid in pregnancy and lactationSCHINDEWOLF, Marc; MOSCH, Gerlinde; BAUERSACHS, Rupert M et al.Thrombosis and haemostasis. 2004, Vol 92, Num 1, issn 0340-6245, p. 211Article

Antithrombins : their potential as antithrombotic agentsWEITZ, J. I; HIRSH, J.Annual review of medicine. 1992, Vol 43, pp 9-16, issn 0066-4219Article

Un accident rare des anticoagulants: l'hémopéritoine par rupture vésiculaire: revue de la littérature à propos d'un cas = A rare complication of anticoagulant therapy: hemoperitoneum due to vesicular rupturePISSAS, A; DANEL, V; FINET, P et al.Journal de chirurgie (Paris. 1908). 1985, Vol 122, Num 4, pp 235-245, issn 0021-7697Article